Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.59 | 23.48 | 39.66 | 27.27 | 29.39 | 31.25 | 38.09 | 18.85 | 31.60 | 22.29 | 29.05 | 29.30 |
| Expenses | 25.16 | 24.66 | 35.58 | 26.82 | 26.50 | 27.08 | 33.41 | 18.56 | 26.59 | 18.29 | 25.15 | 23.49 |
| Operating Profit | 4.43 | -1.18 | 4.08 | 0.45 | 2.89 | 4.17 | 4.68 | 0.29 | 5.01 | 4.00 | 3.90 | 5.81 |
| OPM % | 14.97% | -5.03% | 10.29% | 1.65% | 9.83% | 13.34% | 12.29% | 1.54% | 15.85% | 17.95% | 13.43% | 19.83% |
| Other Income | 0.00 | 0.00 | 0.06 | 0.00 | 0.01 | 0.00 | 0.08 | 0.04 | 0.01 | -0.44 | -0.07 | -0.04 |
| Interest | 0.39 | 0.32 | 0.37 | 0.41 | 0.44 | 0.51 | 0.52 | 0.46 | 0.66 | 0.25 | 0.31 | 0.31 |
| Depreciation | 1.38 | 1.45 | 1.59 | 1.29 | 1.33 | 1.37 | 1.50 | 1.41 | 1.51 | 1.67 | 1.75 | 1.60 |
| Profit before tax | 2.66 | -2.95 | 2.18 | -1.25 | 1.13 | 2.29 | 2.74 | -1.54 | 2.85 | 1.64 | 1.77 | 3.86 |
| Tax % | 22.56% | -22.03% | 30.73% | -26.40% | 31.86% | 35.37% | 18.61% | -28.57% | 27.72% | 14.63% | 39.55% | 25.65% |
| Net Profit | 2.07 | -2.29 | 1.52 | -0.92 | 0.78 | 1.48 | 2.23 | -1.10 | 2.06 | 1.40 | 1.07 | 2.88 |
| EPS in Rs | 1.81 | -2.00 | 1.33 | -0.80 | 0.68 | 1.29 | 1.95 | -0.96 | 1.80 | 1.22 | 0.93 | 2.52 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 74 | 79 | 97 | 137 | 131 | 126 | 133 | 141 | 128 | 126 | 102 | 112 |
| Expenses | 63 | 69 | 94 | 121 | 116 | 98 | 115 | 131 | 116 | 114 | 89 | 94 |
| Operating Profit | 11 | 10 | 3 | 17 | 15 | 29 | 18 | 10 | 12 | 12 | 13 | 19 |
| OPM % | 14% | 13% | 3.4% | 12% | 12% | 23% | 14% | 7% | 9% | 10% | 13% | 17% |
| Other Income | 0 | 1 | 0 | 1 | 4 | 1 | 1 | 0 | 0 | 0 | -0 | -1 |
| Interest | 5 | 4 | 4 | 4 | 3 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 7 |
| Profit before tax | 2 | 3 | -5 | 10 | 12 | 24 | 14 | 4 | 5 | 5 | 5 | 10 |
| Tax % | 55% | 39% | -31% | 30% | 30% | 29% | 25% | 8% | 28% | 27% | 27% | |
| Net Profit | 1 | 2 | -3 | 7 | 8 | 17 | 10 | 4 | 4 | 4 | 3 | 7 |
| EPS in Rs | 0.63 | 1.39 | -2.82 | 6.02 | 7.41 | 14.95 | 9.07 | 3.61 | 3.14 | 3.11 | 3.00 | 6.47 |
| Dividend Payout % | 0% | 0% | 0% | 11% | 14% | 20% | 33% | 55% | 48% | 48% | 50% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 3% | -4% | -10% | -5% | ||
| Compounded Profit Growth | 18% | -26% | -3% | 131% | ||
| Stock Price CAGR | % | -12% | -6% | 22% | ||
| Return on Equity | 11% | 7% | 5% | 5% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 26 | 27 | 28 | 25 | 33 | 39 | 49 | 56 | 57 | 58 | 60 | 62 |
| Borrowings | 45 | 37 | 33 | 31 | 28 | 16 | 10 | 3 | 6 | 12 | 17 | 8 |
| Other Liabilities | 34 | 35 | 20 | 25 | 37 | 30 | 21 | 18 | 32 | 37 | 23 | 22 |
| Total Liabilities | 109 | 103 | 85 | 85 | 101 | 88 | 92 | 88 | 106 | 118 | 112 | 104 |
| Fixed Assets | 35 | 32 | 30 | 30 | 30 | 32 | 31 | 33 | 37 | 40 | 45 | 47 |
| CWIP | 1 | 1 | 1 | 1 | 2 | 0 | 1 | 1 | 2 | 1 | 3 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 72 | 69 | 54 | 54 | 69 | 56 | 60 | 53 | 66 | 77 | 64 | 54 |
| Total Assets | 109 | 103 | 85 | 85 | 101 | 88 | 92 | 88 | 106 | 118 | 112 | 104 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 9 | 14 | 9 | 5 | 12 | 21 | 23 | 2 | 12 | 4 | 10 | 22 |
| Cash from Investing Activity | -1 | 0 | -0 | -3 | -4 | -5 | -3 | 7 | -10 | -7 | -11 | -9 |
| Cash from Financing Activity | -8 | -14 | -9 | -2 | -5 | -17 | -7 | -12 | -2 | 3 | 1 | -12 |
| Net Cash Flow | -1 | -0 | 0 | 0 | 2 | -1 | 13 | -3 | 0 | -0 | -0 | 1 |
| Free Cash Flow | 7 | 13 | 8 | 1 | 7 | 17 | 19 | -4 | 3 | -4 | -2 | 14 |
| CFO/OP | 184% | 128% | 93% | 159% | 71% | 160% | 101% | 33% | 136% | 46% | 100% | 182% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 95 | 97 | 95 | 97 | 68 | 62 | 78 | 96 | 117 | 94 | 69 |
| Inventory Days | 123 | 166 | 145 | 126 | 92 | 75 | 100 | 91 | 96 | 150 | 151 | 228 |
| Days Payable | 106 | 128 | 123 | 130 | 120 | 97 | 81 | 50 | 98 | 144 | 85 | 111 |
| Cash Conversion Cycle | 120 | 133 | 119 | 92 | 68 | 46 | 80 | 118 | 93 | 123 | 160 | 186 |
| Working Capital Days | 2 | 8 | 1 | 7 | 78 | 32 | 52 | 99 | 73 | 94 | 92 | 85 |
| ROCE % | 0% | 9% | 10% | -1% | 21% | 25% | 39% | 21% | 7% | 8% | 8% | 8% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 63.58% | 63.60% | 63.84% | 63.87% | 63.87% | 63.87% | 64.73% | 64.73% | 64.73% | 64.73% | 64.73% | 64.73% |
| Public | 36.43% | 36.41% | 36.16% | 36.12% | 36.13% | 36.13% | 35.27% | 35.27% | 35.28% | 35.27% | 35.27% | 35.27% |
| No. of Shareholders | 5,605 | 5,752 | 5,877 | 5,869 | 5,972 | 5,959 | 5,905 | 6,047 | 6,356 | 6,187 | 6,035 | 5,959 |
Fundamentals
Market Cap₹ 178 Cr.
Current Price₹ 156
Stock P/E22.4
Book Value₹ 64.2
ROCE7.99 %
ROE5.17 %
Dividend Yield0.96 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-5%
Compounded Profit Growth (TTM)131%
Standalone figures.
Valuation
Market capRs 177 Cr
Enterprise valueRs 183 Cr
P/E (TTM)23.88x
Price to book2.41x
Price to sales1.58x
EV / EBITDA10.07x
EV / EBIT15.71x
EV / sales1.63x
Price to cash flow7.95x
Earnings yield4.19%
Dividend yield0.97%
P/E, 3-year average38.08x
P/B, 3-year average1.89x
P/E, 5-year average34.91x
P/B, 5-year average2.33x
Profitability
Operating margin (excl. other income)12.78%
Operating margin (incl. other income)12.44%
EBITDA margin16.20%
Pre-tax margin9.02%
Net profit margin6.60%
Net margin, latest quarter9.83%
ROE4.73%
ROCE7.45%
ROA3.19%
ROE, 3-year average4.99%
ROCE, 3-year average7.88%
ROA, 3-year average3.16%
ROE, 5-year average7.47%
ROCE, 5-year average10.41%
ROA, 5-year average5.07%
ROIC (approx.)10.74%
Tax rate26.61%
Other income / net worth-0.46%
Growth
Sales growth (latest year)-19.08%
Profit growth (latest year)-3.65%
Sales CAGR, 3 years-10.25%
Sales CAGR, 5 years-4.22%
Profit CAGR, 3 years-6.00%
Profit CAGR, 5 years-27.49%
Sales growth QoQ0.86%
Profit growth QoQ169.16%
Sales growth YoY (latest quarter)55.44%
Per share
EPS (TTM)Rs 6.47
EPS (latest year)Rs 3.00
EPS (latest quarter)Rs 2.52
EPS, 3-year averageRs 3.08
EPS, 5-year averageRs 4.38
Book value per shareRs 64.23
Sales per shareRs 98.06
Cash flow per shareRs 19.45
Free cash flow per shareRs 12.23
Dividend per share (latest year)Rs 1.50
Dividend per share, 3-year averageRs 1.50
Dividend per share, 5-year averageRs 1.90
Dividends
Dividend payout50.15%
Dividend payout, 3-year average48.79%
Dividend payout, 5-year average46.99%
Efficiency
Asset turnover0.98x
Fixed asset turnover2.17x
Inventory turnover2.25x
Inventory days162 days
Debtor days69 days
Debtors turnover5.28x
Creditor days111 days
Cash conversion cycle186 days
Working capital days85 days
Leverage
Total debtRs 8 Cr
Cash and bankRs 2 Cr
Net debtRs 6 Cr
Debt to equity0.11x
Net debt / EBITDA0.34x
Interest coverage7.61x
Owners' fund to total sources70.99%
Debt to assets8.07%
Cash flow
Cash from Operating Activity (latest year)Rs 22 Cr
Cash from Investing Activity (latest year)Rs -9 Cr
Cash from Financing Activity (latest year)Rs -12 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs 14 Cr
FCFE (approx.: FCF + change in debt)Rs 6 Cr
Cash from ops / profit, 5 years2.00x
Sales to cash flow4.58x
Statement figures
Net sales (TTM)Rs 112 Cr
Net sales (latest year)Rs 102 Cr
Sales (latest quarter)Rs 29 Cr
Operating profit excl. other income (latest year)Rs 13 Cr
Operating profit (latest quarter)Rs 6 Cr
Other income (TTM)Rs -1 Cr
EBITDA (TTM)Rs 18 Cr
PBDT (TTM)Rs 17 Cr
Profit before tax (TTM)Rs 10 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 7 Cr
Net profit (latest year)Rs 3 Cr
Net profit (latest quarter)Rs 3 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 2 Cr
Cost of goods sold (latest year)Rs 64 Cr
Total expenditure (latest year)Rs 89 Cr
Total income (latest year)Rs 102 Cr
Share capitalRs 11 Cr
ReservesRs 62 Cr
Shareholders' fundsRs 74 Cr
Total assetsRs 104 Cr
Net blockRs 47 Cr
Capital work in progressRs 3 Cr
InvestmentsRs 0 Cr
ReceivablesRs 19 Cr
InventoryRs 28 Cr
Other liabilitiesRs 22 Cr
Shares outstanding (crore)1.14
Ownership
Promoter holding64.73% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 23.9 is at the 51th percentile of its own 8.2-year range
(median 23.2, low 4.1, high 52.8).
P/B 2.41 is at the 60th percentile (median 2.09).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 540686 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.3% | -2.8% | -0.5 pts |
| 1 month | +10.3% | -6.8% | +17.1 pts |
| 3 months | +32.5% | -7.6% | +40.1 pts |
| 3 years | -17.5% | +14.2% | -31.7 pts |
| 5 years | -47.9% | +27.9% | -75.8 pts |
Red flags
F-score 7 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹29 Cr +55.4% vs Jun 2025.
Net profit ₹3 Cr +361.8%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Smruthi Organics Ltd?
Smruthi Organics Ltd (540686) has a market capitalisation of Rs 178 Cr. at the 2026-10-01 close.
What is the P/E ratio of Smruthi Organics Ltd?
Smruthi Organics Ltd trades at a P/E of 22.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Smruthi Organics Ltd's latest quarterly results?
In the Jun 2026 quarter, Smruthi Organics Ltd sales was Rs 29 Cr (+55.4% vs Jun 2025) and net profit was Rs 3 Cr.